a16z Podcast

Pandemics: Early Detection, Networks, Spreaders

Episode Summary

with @nachristakis @jorgecondebio Going from rapid warning to early detection through social network sensors can make all the difference when it comes to contagion/ the spread of disease and pandemics. Can we get public health bio surveillance without sacrificing privacy and agency?

Episode Notes

Pandemics are predictable; what's not predictable is the intensity, or the precise timing of arrival. That's where early detection -- not just rapid warning (as with something like Google Flu Trends back in the day), or even delayed warnings (as with CDC flu trackers and such) -- comes in. Because unfortunately, many disease tracking efforts old and new are "like watching the weather forecast a week after you've experienced that weather", observes a16z general partner Jorge Conde.

And this matters for saving lives; for load balancing and allocating resources (ventilators, PPE, supplies); getting back to work; and much more. Even a two-week advantage could have made a huge difference! Which is what sociologist and physician Nicholas Christakis (who directs the Human Nature Lab, part of the Yale Institute for Network Science, and also author of the book Blueprint) learned from the H1N1 pandemic. Specifically, the role of social network "sensors" -- where friends in one's network graph can be like canaries in the proverbial coal mine to help detect pandemics earlier.

In fact, the lab recently released an app called Hunala (which uses information crowdsourced among networks) to determine one's likelihood of contracting flu/ influenza-like or other respiratory illnesses through a personalized daily assessment of risk. Kind of like Waze, but for illnesses not car accidents. So in this episode of the a16z Podcast, the two take that analogy far. They also discuss the role of other mobility data and population flows in China for where and when the pandemic spread; the nuances behind "superspreaders"; how bad is the coronavirus, really; and the near future of "bio-surveillance" -- not just from a personal risk perspective, but from a global public-health perspective... Can we get the holy grail here without sacrificing privacy and agency?